**Core Concept**
Keloids are a type of raised, thickened scar that can occur after skin injury, resulting from an abnormal wound healing process. The underlying principle being tested is the pharmacological management of keloids.

**Why the Correct Answer is Right**
The first-line treatment for keloids is often topical silicone gel or sheeting, which helps to flatten and soften the scar tissue. Silicone works by reducing the inflammation and collagen synthesis associated with keloid formation. It also helps to reduce the tension on the skin, allowing the scar to flatten over time. This treatment is often more effective than other topical treatments, such as corticosteroids or imiquimod, which may be used as adjunctive therapy.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because while intralesional corticosteroids may be used to treat keloids, they are not typically considered the first-line treatment.
**Option B:** This option is incorrect because imiquimod, an immune response modifier, may be used to treat certain types of scars, but it is not typically used as the first-line treatment for keloids.
**Option C:** This option is incorrect because surgical excision of a keloid is often considered a last resort, as it can lead to recurrence and may not address the underlying pathophysiology of the keloid.

**Clinical Pearl / High-Yield Fact**
Silicone gel or sheeting should be used for a minimum of 12-24 months to effectively treat keloids, as the benefits of treatment may not be seen until after this time period.

**Correct Answer:** D.